A carregar...
Severe pneumococcal pneumonia: impact of new quinolones on prognosis
BACKGROUND: Most guidelines have been proposing, for more than 15 years, a β-lactam combined with either a quinolone or a macrolide as empirical, first-line therapy of severe community acquired pneumonia (CAP) requiring ICU admission. Our goal was to evaluate the outcome of patients with severe CAP,...
Na minha lista:
| Main Authors: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2011
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3065411/ https://ncbi.nlm.nih.gov/pubmed/21406091 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-11-66 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|